Press Releases

  • DDi to Exhibit at MedTech Conference 2018

    PHILADELPHIA, PA, PA - Sep 20, 2018 - DDi invites you to join us at the MedTech Conference organized by AdvaMed on 24-26 September 2018 in Philadelphia, PA

    Sep 20, 2018

  • MakroCare to Exhibit at MedTech Conference 2018

    PHILADELPHIA, PA, PA - Sep 19, 2018 - MakroCare invites you to join us at the MedTech Conference organized by AdvaMed on 24-26 September 2018 in Philadelphia, PA

    Sep 18, 2018

  • Rho Recruiting New Team Members at SOCRA Annual Conference

    CHAPEL HILL, NC, UNITED STATES - Sep 18, 2018 - WHAT:                 Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions, including clinical research associates (CRAs) and project managers, and will be looking to meet potential applicants during the upcoming Society of Clinical Research Associates (SOCRA) Annual Conference in New Orleans, Louisiana, September 28-30, 2018

    Sep 18, 2018

  • Certara Acquires Pirana™, a Leading Pharmacometrics Modeling Workbench

    PRINCETON, NJ, US - Sep 13, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today that it has acquired Pirana, a widely used product for connecting and organizing pharmacometric modeling results as well as providing interfaces to a range of software tools used in pharmacometrics modeling

    Sep 13, 2018

  • MR Solutions’ Founder shortlisted for the 2018 NatWest Great British Entrepreneur Awards

    GUILDFORD, UNITED KINGDOM - Sep 12, 2018 - MR Solutions' Founder shortlisted for the 2018 NatWest Great British Entrepreneur Awards Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards

    Sep 12, 2018

  • Rho Ranks First for Extra-Large Company by Triangle Business Journal Best Places to Work

    CHAPEL HILL, NC - Sep 11, 2018 - For Immediate releaseRho Ranks First for Extra-Large Company byTriangle Business Journal Best Places to WorkCRO recognized for its company culture and flexible work environmentChapel Hill, NC - September 11, 2018  - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Triangle Business Journal has ranked the company as the number one extra-large company

    Sep 11, 2018

  • PAREXEL Advances Patient-Centric Drug Development with Introduction of its Patient Innovation Center

    LINCOLN, UNITED KINGDOM - Sep 11, 2018 - BOSTON, September 11, 2018 - PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access

    Sep 11, 2018

  • BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay

    WESTBURY, NY, US - Sep 10, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology

    Sep 10, 2018

  • BioIVT Launches Dissociated Tumor Cell (DTC) Product Line to Advance Oncology Research

    WESTBURY, NY, US - Sep 6, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced the addition of a dissociated tumor cell (DTC) product line to its immunology portfolio

    Sep 6, 2018

  • Certara Appoints Dr. Mark Holbrook to Lead Its Quantitative Systems Toxicology and Safety Division

    PRINCETON, NJ, US - Sep 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative systems toxicology and safety (QSTS)

    Sep 5, 2018

  • CRF Health Partners Innovative US Biotech with TrialMax® eCOA Solution for Phase III Prostate Oncology Study

    PLYMOUTH MEETING, PA - Aug 30, 2018 - CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced that its TrialMax® Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study

    Aug 30, 2018

  • Greenphire Named to Inc. 5000 List for Sixth Consecutive Year

    KING OF PRUSSIA, PA - Aug 29, 2018 - Greenphire, the global leader in financial software for clinical trials, today announced that it has been named to the 2018 Inc

    Aug 29, 2018

  • The Pistoia Alliance Announces Number of Reactions in its Chemical Safety Library Service has Increased Four-Fold

    BOSTON, MA - Aug 23, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is today announcing a number of milestones in its Chemical Safety Library (CSL) Service project, launched in March 2017

    Aug 22, 2018

  • ERT Appoints Industry Veteran to Advance eCOA Strategy

    PHILADELPHIA, PA, UNITED STATES - Aug 20, 2018 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced the appointment of Zaher El-Assi as Executive Vice President and Product Line Executive for electronic Clinical Outcome Assessments (eCOA)

    Aug 20, 2018

  • CRF Health Launches Self-Service Model for TrialConsent® Platform

    PLYMOUTH MEETING, PA - Aug 20, 2018 - CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industry’s first electronic informed consent platform with fully embedded design tool

    Aug 20, 2018

  • Certara’s D360 Version 10.5 Extends Platform’s Ability to Optimize Discovery Research Across Therapeutic Modalities

    PRINCETON, NJ - Aug 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of D360 v10

    Aug 15, 2018

  • ActiveRADAR Expands Leadership Team to Support Industry Demand, Company Momentum

    SACRAMENTO, CA, UNITED STATES - Aug 14, 2018 - ActiveRADAR (formerly known as RxTE Health), a company specializing in pharmacy cost reduction programs for employers, today announced the addition of three healthcare executives to its leadership team

    Aug 14, 2018

  • TULA Recognized As The 10 Most Trusted Risk and Compliance Solution Providers

    NEW JERSEY, NJ - Aug 14, 2018 - Now a days, the risk and compliance solutions are empowering companies to create and coordinate, to control and map solutions to regulatory & internal compliance requirement as well

    Aug 14, 2018

  • ALBUMEDIX ANNOUNCES EVALUATION AGREEMENT WITH A TOP PHARMA COLLABORATOR

    NNOTTINGHAM, UNITED KINGDOM - Aug 1, 2018 - Nottingham, UK, August 1st – Novartis and Albumedix Ltd. (‘Albumedix’) have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis® technology platform and associated technologies

    Aug 1, 2018

  • Certara Experts Highlight Quantitative Systems Pharmacology’s Role in First-in-Human Clinical Trials

    PRINCETON, NJ - Jul 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its “Letter to the Editor” describing the important role that quantitative systems pharmacology (QSP) can play in defining dosing criteria for first-in-human (FIH) clinical trials,1 together with the European Medicines Agency’s (EMA’s) response

    Jul 26, 2018